Sprinter Health operates an at-home care service that delivers preventative clinical services including blood draws, diabetes eye checks, and colorectal cancer screenings. Its core technology is a logistics and route-simulation system that optimizes schedules for clinical staff, phlebotomists cross-trained as medical assistants, and community health workers to maximize patient visits. The company says staff can serve up to 12 patients daily and that services are free to members of its health insurance partners, including Medicare and Medicaid. Sprinter has expanded rapidly, operating in 18 states (up from five in 2023) and reporting a six-fold revenue increase year-over-year. The model aims to re-engage patients who haven’t been using the health system and improve long-term health outcomes. The company has focused on tight operating systems to make at-home care unit economics sustainable. Sprinter Health is an on-demand mobile health company that dispatches fully-employed nurses and phlebotomists ('Sprinters') into patients' homes to perform lab draws, vitals checks, and COVID-19 testing. The company provides online booking, fasting reminders, ETA texts, and follow-up instructions to make in-home clinical services convenient and affordable. It partners with specialty labs, physician practices, insurers, employers, and healthcare providers to increase testing adherence and reduce the need for travel or missed work. Sprinter Health matches the appropriate licensed clinician to each medical need and uses a customized 'Sprinter Checklist' to deliver care with high quality and low error rates. The company is operating in the San Francisco Bay Area and Sacramento and plans to expand to Los Angeles and San Diego by the end of 2021, with further expansion targeted to Texas and Florida in 2022. Financially, Sprinter announced a $33 million Series A and previously raised a $4.6 million seed round; it will use the Series A proceeds to expand its last-mile in-home healthcare services into new markets.

Total raised

$88M

Funding rounds

2

Latest round

Series B

Latest activity

May 2025